Clinical trials

2

Search and review clinical trials. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Recruiting

WIRE - Novel Treatments in Renal Cell Cancer

Evaluation of proof of mechanism with relation to ktrans and/or CD8 count when different IMPs are given as monotherapy or as combination therapy. These would be administered in the "window of opportunity", prior to nephrectomy in surgically resectable renal cell cancer

Participants needed: 134
Trial details
Phase: Phase 2Age: 18+Biological sex: AllType: InterventionalSponsor: CCTU- Cancer ThemeUpdated: Sep 25, 2026Locations: 7
Eligibility criteria

Aged ≥18 years and over. [+26]

cT1a N0 M0-staged Renal Cell Cancer [+56]

Status: Recruiting

Heuristics, Algorithms and Machine Learning: Evaluation & Testing in Radiation Therapy

The Hamlet.rt study is a prospective data collection and patient questionnaire study for patients undergoing image-guided radiotherapy with curative intent. The aim of the study is to use novel machine learning and mathematical techniques to build a model that can predict the risk of significant side effects from radiotherapy treatment for an individual patient: using calculations of normal tissue dose from radiotherapy treatment planning and patient baseline characteristics derived from image and non-image data, continuously updated as the patient is reviewed both during and after treatment. A secondary goal of the project is to facilitate research in machine learning and medical image processing for radiation therapy through the creation of a discoverable and shared data resource for research use.

Participants needed: 310
Trial details
Age: 18+Biological sex: AllType: ObservationalSponsor: CCTU- Cancer ThemeUpdated: Aug 2, 2021Locations: 1Duration: 5 Years
Eligibility criteria

Participant is willing and able to give informed consent for participation in th... [+7]

Participant is not willing or able to complete the protocol-stated requirements...